Search for: "AKZO Nobel NV"
Results 1 - 10
of 10
Sort by Relevance
|
Sort by Date
27 Dec 2021, 10:13 am
Akzo Nobel NV ea). [read post]
17 Jan 2020, 8:56 am
The decision directs us to Lewison J’s comment in Ivax Pharmaceuticals v Akzo Nobel NV [2006] which states that “obstacles to regulatory approval….are not relevant obstacles to an obviousness attack”. [read post]
21 Mar 2018, 3:35 am
The Court of Appeal, following Cartel Damage Claims (CDC) Hydrogen Peroxide SA v Akzo Nobel NV (C-352/13) [2015] QB 906, correctly identified the place where the conspiratorial agreement was made as the place of the event which gives rise to and is at the origin of the damage. [read post]
18 Feb 2012, 9:11 am
., Organon Pharmaceuticals, Akzo Nobel NV and Schering-Plough Corporation as defendants. [read post]
3 Nov 2011, 10:44 am
., and Akzo Nobel NV. [read post]
29 Sep 2010, 6:11 am
The case arose from the European Commission’s Directorate General for Competition’s dawn raid of Dutch chemicals group Akzo Nobel NV in February 2003. [read post]
19 Sep 2010, 10:39 pm
(IP tango) Canada World Economic Forum ranks Canada ahead of US, Japan, UK on IP protection (Michael Geist) Millions at stake in education copyright battle (Michael Geist) China SIPO proposes to amend rules on administrative enforcement of patent rights (China Law Blog) Europe ECJ denies legal privilege for in-house lawyers in competition law cases: Case 550/07 P Akzo Nobel Chemicals Ltd. and Akcros Chemicals Ltd. v the Commission of the European Communities (EPLAW) (PatLit) (IAM)… [read post]
14 Sep 2010, 10:41 am
Story here at The Lawyer, and covered lots of places in the blawgosphere. [read post]
20 Apr 2010, 5:07 pm
., Akzo Nobel NV, Organon Biosciences, N.V., and Schering-Plough Corporation, not only knew about the potential side effects associated with NUVARING®, but concealed those risks from the public, including the FDA during the approval process. [read post]
17 Dec 2007, 10:14 am
The defendants included Akzo Nobel NV, a Dutch company, and its Organon subsidiary, which has its principal place of business in New Jersey. [read post]